In Vivo Evidence Of Cftr Activation By Roflumilast: A Potential Mechanism Underlying Therapeutic Benefit Of Roflumilast In COPD

被引：0
|
作者：
Raju, S. [1 ]
Tang, L. [1 ]
Rowe, S. M. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6013
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo
    Fleisher-Berkovich, Sigal
    Ventura, Yvonne
    Amoyal, Maya
    Dahan, Arik
    Feinshtein, Valeria
    Alfahel, Leenor
    Israelson, Adrian
    Bernstein, Nirit
    Gorelick, Jonathan
    Ben-Shabat, Shimon
    BIOMOLECULES, 2023, 13 (02)
  • [42] Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets
    Vizan, Pedro
    Sanchez-Tena, Susana
    Alcarraz-Vizan, Gema
    Soler, Marta
    Messeguer, Ramon
    Pujol, M. Dolors
    Lee, Wai-Nang Paul
    Cascante, Marta
    CARCINOGENESIS, 2009, 30 (06) : 946 - 952
  • [43] Therapeutic potential of a prominent dihydroxyflavanone pinocembrin for osteolytic bone disease: In vitro and in vivo evidence
    Hong, Guoju
    Li, Shuqiang
    Zheng, Guanqiang
    Zheng, Xiaoxia
    Zhan, Qunzhang
    Zhou, Lin
    Wei, Qiushi
    He, Wei
    Chen, Zhenqiu
    JOURNAL OF ORTHOPAEDIC TRANSLATION, 2024, 45 : 197 - 210
  • [44] Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy
    Egom, Emmanuel E.
    Rose, Robert A.
    Neyses, Ludwig
    Soran, Handrean
    Cleland, John G. F.
    Mamas, Mamas A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2013, 50 (03) : 79 - 89
  • [45] The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and in vivo validation
    Zeng, Li
    Tang, Yiping
    Zhang, Yichen
    Yue, Li
    Ma, Gang
    Ye, Xumin
    Yang, Lijing
    Chen, Kai
    Zhou, Qiao
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Curcumin as a potential therapeutic option for NAFLD and other metabolic diseases: need for establishing the underlying mechanism(s) of action
    Ghosh, Shobha
    HEPATOLOGY INTERNATIONAL, 2019, 13 (03) : 245 - 247
  • [47] Exploring the Therapeutic Potential and Underlying Mechanism of Bergapten in Renal Fibrosis: Network Pharmacology, Molecular Docking, and Experimental Validation
    Gairola, Shobhit
    Saini, Montu
    Bhatta, Archana
    Kaundal, Ravinder K.
    PHYTOTHERAPY RESEARCH, 2025,
  • [48] Curcumin as a potential therapeutic option for NAFLD and other metabolic diseases: need for establishing the underlying mechanism(s) of action
    Shobha Ghosh
    Hepatology International, 2019, 13 : 245 - 247
  • [49] Exploring the underlying biology of cancer and potential therapeutic strategies: a special issue focused on mechanism-based studies
    Gao, Daming
    Ge, Gaoxiang
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (06) : 891 - 892
  • [50] Proteasome Activation is a Mechanism for Pyrazolone Small Molecules Displaying Therapeutic Potential in Amyotrophic Lateral Sclerosis
    Trippier, Paul C.
    Zhao, Kevin Tianmeng
    Fox, Susan G.
    Schiefer, Isaac T.
    Benmohamed, Radhia
    Moran, Jason
    Kirsch, Donald R.
    Morimoto, Richard I.
    Silverman, Richard B.
    ACS CHEMICAL NEUROSCIENCE, 2014, 5 (09): : 823 - 829
12345